-
1
-
-
84870294267
-
Progressive activation of T(H)2/T (H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
-
Gittler JK, Shemer A, Suarez-Farinas M, et al. Progressive activation of T(H)2/T (H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012;130:1344-54
-
(2012)
J Allergy Clin Immunol
, vol.130
, pp. 1344-1354
-
-
Gittler, J.K.1
Shemer, A.2
Suarez-Farinas, M.3
-
2
-
-
63049099730
-
Prevalence of atopic dermatitis in Italian schoolchildren: Factors affecting its variation
-
Naldi L, Parazzini F, Gallus S. Prevalence of atopic dermatitis in Italian schoolchildren: factors affecting its variation. Acta Derm Venereol 2009;89:122-5
-
(2009)
Acta Derm Venereol
, vol.89
, pp. 122-125
-
-
Naldi, L.1
Parazzini, F.2
Gallus, S.3
-
3
-
-
84862519737
-
Epidemiology of atopic dermatitis: A review
-
DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc 2012;33:227-34
-
(2012)
Allergy Asthma Proc
, vol.33
, pp. 227-234
-
-
Daveiga, S.P.1
-
5
-
-
84863852536
-
Investigating international time trends in the incidence and prevalence of atopic eczema. 1990-2010: A systematic review of epidemiological studies
-
Deckers IA, McLean S, Linssen S, et al. Investigating international time trends in the incidence and prevalence of atopic eczema. 1990-2010: a systematic review of epidemiological studies. PLoS One 2012;7:e39803
-
(2012)
PLoS One
, vol.7
, pp. e39803
-
-
Deckers, I.A.1
McLean, S.2
Linssen, S.3
-
6
-
-
84878996237
-
New insights into atopic dermatitis: Role of skin barrier and immune dysregulation
-
Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int 2013;62:151-61.
-
(2013)
Allergol Int
, vol.62
, pp. 151-161
-
-
Leung, D.Y.1
-
7
-
-
68349089102
-
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis
-
Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009;9:265-72
-
(2009)
Curr Allergy Asthma Rep
, vol.9
, pp. 265-272
-
-
Elias, P.M.1
Schmuth, M.2
-
8
-
-
37749025593
-
Atopic dermatitis
-
Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94
-
(2008)
N Engl J Med
, vol.358
, pp. 1483-1494
-
-
Bieber, T.1
-
9
-
-
0034871785
-
Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications
-
Elias PM, Feingold KR. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 2001;137:1079-81
-
(2001)
Arch Dermatol
, vol.137
, pp. 1079-1081
-
-
Elias, P.M.1
Feingold, K.R.2
-
10
-
-
79955622264
-
Contrasting pathogenesis of atopic dermatitis and psoriasis - part II: Immune cell subsets and therapeutic concepts
-
Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis - part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011;127:1420-32
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 1420-1432
-
-
Guttman-Yassky, E.1
Nograles, K.E.2
Krueger, J.G.3
-
12
-
-
78649997637
-
Atopic dermatitis in older patients: Particular points
-
Katsarou A, Armenaka M. Atopic dermatitis in older patients: particular points. J Eur Acad Dermatol Venereol 2011;25(1):12-18
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, Issue.1
, pp. 12-18
-
-
Katsarou, A.1
Armenaka, M.2
-
13
-
-
17844388588
-
Adult-onset atopic dermatitis
-
Ozkaya E. Adult-onset atopic dermatitis. J Am Acad Dermatol 2005;52:579-82
-
(2005)
J Am Acad Dermatol
, vol.52
, pp. 579-582
-
-
Ozkaya, E.1
-
14
-
-
0042530486
-
Allergic and nonallergic forms of atopic diseases
-
Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003;112:252-62
-
(2003)
J Allergy Clin Immunol
, vol.112
, pp. 252-262
-
-
Novak, N.1
Bieber, T.2
-
15
-
-
0035188697
-
Early life risk factors for adult asthma: A birth cohort study of subjects at risk
-
Rhodes HL, Sporik R, Thomas P, et al. Early life risk factors for adult asthma: a birth cohort study of subjects at risk. J Allergy Clin Immunol 2001;108:720-5
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 720-725
-
-
Rhodes, H.L.1
Sporik, R.2
Thomas, P.3
-
16
-
-
18744375442
-
The development of childhood asthma: Lessons from the German Multicentre Allergy Study (MAS)
-
Lan S, Nickel R, Niggemann B, et al. The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatr Respir Rev 2002;3:265-72
-
(2002)
Paediatr Respir Rev
, vol.3
, pp. 265-272
-
-
Lan, S.1
Nickel, R.2
Niggemann, B.3
-
18
-
-
84866883929
-
Current issues in atopic comorbidities and preventing the atopic march
-
Simpson EL, Eichenfield LF, Ellis CN, et al. Current issues in atopic comorbidities and preventing the atopic march. Semin Cutan Med Surg 2012;31:S6-9
-
(2012)
Semin Cutan Med Surg
, vol.31
, pp. S6-9
-
-
Simpson, E.L.1
Eichenfield, L.F.2
Ellis, C.N.3
-
19
-
-
33750891885
-
Atopic dermatitis in children, Part 1: Epidemiology, clinical features, and complications
-
Kiken DA, Silverberg NB. Atopic Dermatitis in Children, Part 1: epidemiology, Clinical Features, and Complications. Cutis 2006;78:241-7
-
(2006)
Cutis
, vol.78
, pp. 241-247
-
-
Kiken, D.A.1
Silverberg, N.B.2
-
21
-
-
84866863667
-
Understanding and managing atopic dermatitis in adult patients
-
Ellis CN, Mancini AJ, Paller AS, et al. Understanding and managing atopic dermatitis in adult patients. Semin Cutan Med Surg 2012;31:S18-22
-
(2012)
Semin Cutan Med Surg
, vol.31
, pp. S18-22
-
-
Ellis, C.N.1
Mancini, A.J.2
Paller, A.S.3
-
22
-
-
84865085421
-
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
-
Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol 2012;26:1176-93
-
(2012)
J Eur Acad Dermatol Venereol
, vol.26
, pp. 1176-1193
-
-
Ring, J.1
Alomar, A.2
Bieber, T.3
-
24
-
-
79961006747
-
A randomized trial of methotrexate versus azathioprine for severe atopic eczema
-
Schram ME, Roekevisch E, Leeflang MM, et al. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011;128:353-9
-
(2011)
J Allergy Clin Immunol
, vol.128
, pp. 353-359
-
-
Schram, M.E.1
Roekevisch, E.2
Leeflang, M.M.3
-
25
-
-
79956127410
-
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trial
-
Haeck IM, Knol MJ, Ten Berge O, et al. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011;64:1074-84
-
(2011)
J Am Acad Dermatol
, vol.64
, pp. 1074-1084
-
-
Haeck, I.M.1
Knol, M.J.2
Ten Berge, O.3
-
27
-
-
20244375866
-
Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis
-
Oldhoff JM, Darsow U, Werfel T, et al. Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis. Allergy 2005;60:693-6
-
(2005)
Allergy
, vol.60
, pp. 693-696
-
-
Oldhoff, J.M.1
Darsow, U.2
Werfel, T.3
-
28
-
-
35748968191
-
Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels
-
Belloni B, Ziai M, Lim A, et al. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J All Clini Immunol 2007;120:1223-5
-
(2007)
J All Clini Immunol
, vol.120
, pp. 1223-1225
-
-
Belloni, B.1
Ziai, M.2
Lim, A.3
-
29
-
-
38149055540
-
Anti-CD20 (rituximab) treatment improves atopic eczema
-
Simon D, Hosli S, Kostylina G, et al. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol 2008;121:122-8
-
(2008)
J Allergy Clin Immunol
, vol.121
, pp. 122-128
-
-
Simon, D.1
Hosli, S.2
Kostylina, G.3
-
30
-
-
77955296598
-
Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy
-
Ponte P, Lopes MJ. Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy. J Am Acad Dermatol 2010;63:355-6
-
(2010)
J Am Acad Dermatol
, vol.63
, pp. 355-356
-
-
Ponte, P.1
Lopes, M.J.2
-
32
-
-
80055076585
-
Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection
-
Navarini AA, French LE, Hofbauer DF. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J All Clin Immunol 2011;128:1128-30
-
(2011)
J All Clin Immunol
, vol.128
, pp. 1128-1130
-
-
Navarini, A.A.1
French, L.E.2
Hofbauer, D.F.3
-
33
-
-
84873113151
-
IL-4 upregulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: Relevant in the pathogenesis of atopic dermatitis
-
Bao L, Shi VY, Chan LS. IL-4 upregulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis. Cytokine 2013;61:419-25.
-
(2013)
Cytokine
, vol.61
, pp. 419-425
-
-
Bao, L.1
Shi, V.Y.2
Chan, L.S.3
-
34
-
-
67649238893
-
Meta-analysis of filaggrin polymorphisms in eczema and asthma: Robust risk factors in atopic disease
-
Rodriguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009;123:1361-70
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 1361-1370
-
-
Rodriguez, E.1
Baurecht, H.2
Herberich, E.3
-
35
-
-
33847025339
-
Fleshing out filaggrin phenotypes
-
Irvine AD. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007;127:504-7
-
(2007)
J Invest Dermatol
, vol.127
, pp. 504-507
-
-
Irvine, A.D.1
-
36
-
-
0001325237
-
The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
-
Hershey GK, Friedrich MF, Esswein LA, et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997;337:1720-5
-
(1997)
N Engl J Med
, vol.337
, pp. 1720-1725
-
-
Hershey, G.K.1
Friedrich, M.F.2
Esswein, L.A.3
-
39
-
-
76149138494
-
Reduced IFN-gamma- and enhanced IL-4-producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis
-
Herberth G, Heinrich J, Röder S, et al. Reduced IFN-gamma- and enhanced IL-4-producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis Pediatr Allergy Immunol. 2010;21:5-13
-
(2010)
Pediatr Allergy Immunol
, vol.21
, pp. 5-13
-
-
Herberth, G.1
Heinrich, J.2
Röder, S.3
-
40
-
-
0024391538
-
Hyperresponsibility to exogeneous interleukin 4 in atopic dermatitis
-
Furue M, Ogata F, Ootsuki M, Ishibashi Y. Hyperresponsibility to exogeneous interleukin 4 in atopic dermatitis. J Dermatol 1989;16:247-50
-
(1989)
J Dermatol
, vol.16
, pp. 247-250
-
-
Furue, M.1
Ogata, F.2
Ootsuki, M.3
Ishibashi, Y.4
-
42
-
-
0025829192
-
Interleukin-4 promotes the expansion of skin-infiltrating lymphocytes from atopic dermatitis in vitro
-
Reinhold U, Kukel S, Goeden B, et al. Interleukin-4 promotes the expansion of skin-infiltrating lymphocytes from atopic dermatitis in vitro. J Invest Dermatol 1991;96:370-5
-
(1991)
J Invest Dermatol
, vol.96
, pp. 370-375
-
-
Reinhold, U.1
Kukel, S.2
Goeden, B.3
-
43
-
-
0028366137
-
IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals
-
Dubois GR, Bruijnzeel-Koomen CA, Bruijnzeel PL. IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. J Invest Dermatol 1994;102:843-6
-
(1994)
J Invest Dermatol
, vol.102
, pp. 843-846
-
-
Dubois, G.R.1
Bruijnzeel-Koomen, C.A.2
Bruijnzeel, P.L.3
-
44
-
-
0026692094
-
IL-4 controls the selective endotheliumdriven transmigration of eosinophils from allergic individuals
-
Moser R, Fehr J, Bruijnzeel PL. IL-4 controls the selective endotheliumdriven transmigration of eosinophils from allergic individuals. J Immunol 1992;149:1432-8
-
(1992)
J Immunol
, vol.149
, pp. 1432-1438
-
-
Moser, R.1
Fehr, J.2
Bruijnzeel, P.L.3
-
45
-
-
0026759824
-
Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma
-
Renz H, Jujo K, Bradley KL, et al. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992;99:403-8
-
(1992)
J Invest Dermatol
, vol.99
, pp. 403-408
-
-
Renz, H.1
Jujo, K.2
Bradley, K.L.3
-
46
-
-
0028015581
-
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
-
Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6
-
(1994)
J Clin Invest
, vol.94
, pp. 870-876
-
-
Hamid, Q.1
Boguniewicz, M.2
Leung, D.Y.3
-
47
-
-
0029783367
-
In vivo expression of IL-12 and IL-13 in atopic dermatitis
-
Hamid Q, Naseer T, Minshall EM, et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31
-
(1996)
J Allergy Clin Immunol
, vol.98
, pp. 225-231
-
-
Hamid, Q.1
Naseer, T.2
Minshall, E.M.3
-
48
-
-
79952419144
-
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to inteleukin-4 stimulation
-
Gahr N, Fölster-Holst R, Weichenthal M, et al. Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to inteleukin-4 stimulation. Br J Dermatol 2011;164:586-92
-
(2011)
Br J Dermatol
, vol.164
, pp. 586-592
-
-
Gahr, N.1
Fölster-Holst, R.2
Weichenthal, M.3
-
49
-
-
84857054959
-
IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis
-
Bao L, Shi VY, Chan LS. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: implication for atopic dermatitis. Mol Immunol 2012;50:91-7
-
(2012)
Mol Immunol
, vol.50
, pp. 91-97
-
-
Bao, L.1
Shi, V.Y.2
Chan, L.S.3
-
50
-
-
33845647692
-
Interleukin-4 promotes human CD8 T cell expression of CCR7
-
Seneviratne SL, Black AP, Jones L, et al. Interleukin-4 promotes human CD8 T cell expression of CCR7. Immunology 2007;120:66-72
-
(2007)
Immunology
, vol.120
, pp. 66-72
-
-
Seneviratne, S.L.1
Black, A.P.2
Jones, L.3
-
51
-
-
33947635732
-
CCL23 expression is induced by IL-4 in a STAT6-dependent fashion
-
Novak H, Müller A, Harrer N, et al. CCL23 expression is induced by IL-4 in a STAT6-dependent fashion. J Immunol 2007;177:4335-41
-
(2007)
J Immunol
, vol.177
, pp. 4335-4341
-
-
Novak, H.1
Müller, A.2
Harrer, N.3
-
52
-
-
0029922964
-
Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema
-
Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996;106:446-53
-
(1996)
J Invest Dermatol
, vol.106
, pp. 446-453
-
-
Wollenberg, A.1
Kraft, S.2
Hanau, D.3
Bieber, T.4
-
53
-
-
0036431675
-
A reducing microenvironment leads to the generation of FcepsilonRI high inflammatory dendritic epidermal cells (IDEC)
-
Novak N, Kraft S, Haberstok J, et al. A reducing microenvironment leads to the generation of FcepsilonRI high inflammatory dendritic epidermal cells (IDEC). J Invest Dermatol 2002;119:842-9
-
(2002)
J Invest Dermatol
, vol.119
, pp. 842-849
-
-
Novak, N.1
Kraft, S.2
Haberstok, J.3
-
54
-
-
32044437848
-
IL-31: A new link between T cells and pruritus in atopic skin inflammation
-
Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411-17.
-
(2006)
J Allergy Clin Immunol
, vol.117
, pp. 411-417
-
-
Sonkoly, E.1
Muller, A.2
Lauerma, A.I.3
-
55
-
-
79958111386
-
Functional effects of interleukin 31 in human primary keratinocytes
-
Kasraie S, Niebuhr M, Baumert K, Werfel T. Functional effects of interleukin 31 in human primary keratinocytes. Allergy 2011;66:845-52
-
(2011)
Allergy
, vol.66
, pp. 845-852
-
-
Kasraie, S.1
Niebuhr, M.2
Baumert, K.3
Werfel, T.4
-
56
-
-
84881134264
-
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
-
Stott B, Lavender P, Lehmann S, et al. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol 2013;132:446-54
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 446-454
-
-
Stott, B.1
Lavender, P.2
Lehmann, S.3
-
57
-
-
80053517839
-
Filaggrin mutations associated with skin and allergic diseases
-
Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011;365:1315-27
-
(2011)
N Engl J Med
, vol.365
, pp. 1315-1327
-
-
Irvine, A.D.1
McLean, W.H.2
Leung, D.Y.3
-
58
-
-
33645401909
-
Skin barrier function and allergic risk
-
Hudson TJ. Skin barrier function and allergic risk. Nat Genet 2006;38:399-400.
-
(2006)
Nat Genet
, vol.38
, pp. 399-400
-
-
Hudson, T.J.1
-
59
-
-
44649119864
-
Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms
-
Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008;121:1337-43
-
(2008)
J Allergy Clin Immunol
, vol.121
, pp. 1337-1343
-
-
Elias, P.M.1
Hatano, Y.2
Williams, M.L.3
-
60
-
-
41449089071
-
The burden of disease associated with filaggrin mutations: A populationbased, longitudinal birth cohort study
-
Henderson J, Northstone K, Lee SP, et al. The burden of disease associated with filaggrin mutations: a populationbased, longitudinal birth cohort study. J Allergy Clin Immunol 2008;121:872-7
-
(2008)
J Allergy Clin Immunol
, vol.121
, pp. 872-877
-
-
Henderson, J.1
Northstone, K.2
Lee, S.P.3
-
61
-
-
34250828434
-
Cytokine modulation of atopic dermatitis filaggrin skin expression
-
Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007;120:150-5
-
(2007)
J Allergy Clin Immunol
, vol.120
, pp. 150-155
-
-
Howell, M.D.1
Kim, B.E.2
Gao, P.3
-
62
-
-
58849102971
-
Role of T cells in the pathogenesis of atopic dermatitis
-
Ogg G. Role of T cells in the pathogenesis of atopic dermatitis. Clin Exp Allergy 2009;39:310-16
-
(2009)
Clin Exp Allergy
, vol.39
, pp. 310-316
-
-
Ogg, G.1
-
63
-
-
84900845306
-
In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans
-
Omori-Miyake M, Yamashita M, Tsunemi Y, et al. In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans. J Invest Dermatol 2014;134:1342-50
-
(2014)
J Invest Dermatol
, vol.134
, pp. 1342-1350
-
-
Omori-Miyake, M.1
Yamashita, M.2
Tsunemi, Y.3
-
64
-
-
39149098125
-
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
-
Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008;126:332-7.
-
(2008)
Clin Immunol
, vol.126
, pp. 332-337
-
-
Kim, B.E.1
Leung, D.Y.2
Boguniewicz, M.3
Howell, M.D.4
-
65
-
-
16844386596
-
Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis
-
Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol 2005;124:786-92.
-
(2005)
J Invest Dermatol
, vol.124
, pp. 786-792
-
-
Hatano, Y.1
Terashi, H.2
Arakawa, S.3
Katagiri, K.4
-
66
-
-
84871716569
-
The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: Implications for pathogenesis of atopic dermatitis
-
Hatano Y, Adachi Y, Elias PM, et al. The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis. Exp Dermatol 2013;22:30-5
-
(2013)
Exp Dermatol
, vol.22
, pp. 30-35
-
-
Hatano, Y.1
Adachi, Y.2
Elias, P.M.3
-
67
-
-
84862874520
-
TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis
-
Morizane S, Yamasaki K, Kajita A, et al. TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. J All Clin Immunol 2012;130:259-61
-
(2012)
J All Clin Immunol
, vol.130
, pp. 259-261
-
-
Morizane, S.1
Yamasaki, K.2
Kajita, A.3
-
68
-
-
42149101196
-
Outside-to-inside (and now back to "outside") pathogenic mechanisms in atopic dermatitis
-
Elias PM, Steinhoff M. Outside-to-Inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008;128:1067-70
-
(2008)
J Invest Dermatol
, vol.128
, pp. 1067-1070
-
-
Elias, P.M.1
Steinhoff, M.2
-
69
-
-
0035937107
-
Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic
-
Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-13.
-
(2001)
J Biol Chem
, vol.276
, pp. 5707-5713
-
-
Harder, J.1
Bartels, J.2
Christophers, E.3
Schroder, J.M.4
-
70
-
-
0036040263
-
Expression of betadefensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells
-
Duits LA, Ravensbergen B, Rademaker M, et al. Expression of betadefensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002;106:517-25
-
(2002)
Immunology
, vol.106
, pp. 517-525
-
-
Duits, L.A.1
Ravensbergen, B.2
Rademaker, M.3
-
71
-
-
0033569408
-
Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6
-
Yang D, Chertov O, Bykovskaia SN, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-8
-
(1999)
Science
, vol.286
, pp. 525-528
-
-
Yang, D.1
Chertov, O.2
Bykovskaia, S.N.3
-
72
-
-
0142218765
-
Roles of antimicrobialpeptides such as defensins in innate and adaptive immunity
-
Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobialpeptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 2003;62(Suppl 2):ii17-21
-
(2003)
Ann Rheum Dis
, vol.62
, pp. ii17-21
-
-
Oppenheim, J.J.1
Biragyn, A.2
Kwak, L.W.3
Yang, D.4
-
73
-
-
69249091865
-
Antimicrobial peptides and the skin immune defense system
-
Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2009;124:R13-18
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. R13-18
-
-
Schauber, J.1
Gallo, R.L.2
-
74
-
-
0037057645
-
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
-
Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60
-
(2002)
N Engl J Med
, vol.347
, pp. 1151-1160
-
-
Ong, P.Y.1
Ohtake, T.2
Brandt, C.3
-
75
-
-
0041331649
-
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes
-
Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-9
-
(2003)
J Immunol
, vol.171
, pp. 3262-3269
-
-
Nomura, I.1
Goleva, E.2
Howell, M.D.3
-
76
-
-
27744478760
-
Interleukin-10 downregulates antimicrobial peptide expression in atopic dermatitis
-
Howell MD, Novak N, Bieber T, et al. Interleukin-10 downregulates antimicrobial peptide expression in atopic dermatitis. J Invest Dermatol 2005;125:738-45
-
(2005)
J Invest Dermatol
, vol.125
, pp. 738-745
-
-
Howell, M.D.1
Novak, N.2
Bieber, T.3
-
77
-
-
33750139445
-
Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin
-
Yamasaki K, Schauber J, Coda A, et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 2006;20:2068-80
-
(2006)
FASEB J
, vol.20
, pp. 2068-2080
-
-
Yamasaki, K.1
Schauber, J.2
Coda, A.3
-
78
-
-
73149114667
-
Recent insights into atopic dermatitis and implications for management of infectious complications
-
Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010;125(1):4-13
-
(2010)
J Allergy Clin Immunol
, vol.125
, Issue.1
, pp. 4-13
-
-
Boguniewicz, M.1
Leung, D.Y.2
-
79
-
-
33645129371
-
The role of microorganisms in atopic dermatitis
-
Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006;144:1-9
-
(2006)
Clin Exp Immunol
, vol.144
, pp. 1-9
-
-
Baker, B.S.1
-
80
-
-
58149131262
-
IL17 in atopic eczema: Linking allergenspecific adaptive and microbial triggered innate immune response
-
Eyerich K, Pennino D, Scarponi C, et al. IL17 in atopic eczema: linking allergenspecific adaptive and microbial triggered innate immune response. J Allergy Clin Immunol 2009;123:59-66.
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 59-66
-
-
Eyerich, K.1
Pennino, D.2
Scarponi, C.3
-
81
-
-
78649812469
-
Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus
-
Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 2010;126:1184-90
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 1184-1190
-
-
Miajlovic, H.1
Fallon, P.G.2
Irvine, A.D.3
Foster, T.J.4
-
82
-
-
46049112666
-
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3
-
Kisich KO, Carspecken CW, Fieve S, et al. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008;122:62-8
-
(2008)
J Allergy Clin Immunol
, vol.122
, pp. 62-68
-
-
Kisich, K.O.1
Carspecken, C.W.2
Fieve, S.3
-
83
-
-
40649124294
-
Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers
-
Aberg KM, Man MQ, Gallo RL, et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008;128:917-25
-
(2008)
J Invest Dermatol
, vol.128
, pp. 917-925
-
-
Aberg, K.M.1
Man, M.Q.2
Gallo, R.L.3
-
84
-
-
84862189134
-
A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: Possible immunological state of the intrinsic type
-
Kabashima-Kubo R, Nakamura R, Sakabe J, et al. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. J Dermatol Sci 2012;67:37-43.
-
(2012)
J Dermatol Sci
, vol.67
, pp. 37-43
-
-
Kabashima-Kubo, R.1
Nakamura, R.2
Sakabe, J.3
-
85
-
-
77950371618
-
Extrinsic and intrinsic types of atopic dermatitis
-
Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010;58:1-7
-
(2010)
J Dermatol Sci
, vol.58
, pp. 1-7
-
-
Tokura, Y.1
-
86
-
-
84918493008
-
Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals
-
Kägi MK, Wüthrich B, Montano E, et al. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Allergy 2002;57:431-5
-
(2002)
Allergy
, vol.57
, pp. 431-435
-
-
Kägi, M.K.1
Wüthrich, B.2
Montano, E.3
-
87
-
-
84881156451
-
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
-
Suarez-Farinas M, Dhingra N, Gittler J, et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 2013;132:361-70
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 361-370
-
-
Suarez-Farinas, M.1
Dhingra, N.2
Gittler, J.3
-
88
-
-
0347400419
-
Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. Extrinsic atopic dermatitis patients using semiquantitative RT-PCR
-
Jeong CW, Ahn KS, Rho NK, et al. Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 2003;33:1717-24
-
(2003)
Clin Exp Allergy
, vol.33
, pp. 1717-1724
-
-
Jeong, C.W.1
Ahn, K.S.2
Rho, N.K.3
-
89
-
-
0032965547
-
Circulating activation markers of severe atopic dermatitis following ultraviolet A1 cold light phototherapy: Eosinophil cationic protein, soluble interleukin-2 receptor and soluble interleukin-4 receptor
-
von Kobyletzki G, Pieck C, Höxtermann S, et al. Circulating activation markers of severe atopic dermatitis following ultraviolet A1 cold light phototherapy: eosinophil cationic protein, soluble interleukin-2 receptor and soluble interleukin-4 receptor. Br J Dermatol 1999;140:966-8
-
(1999)
Br J Dermatol
, vol.140
, pp. 966-968
-
-
Von Kobyletzki, G.1
Pieck, C.2
Höxtermann, S.3
-
90
-
-
34848850690
-
Establishment of an in vitro test system to evaluate the down-regulatory activities of natural products on IL-4
-
Choi JJ, Park BK, Song GY, et al. Establishment of an in vitro test system to evaluate the down-regulatory activities of natural products on IL-4. Arch Pharm Res 2007;30:1102-10
-
(2007)
Arch Pharm Res
, vol.30
, pp. 1102-1110
-
-
Choi, J.J.1
Park, B.K.2
Song, G.Y.3
-
91
-
-
84918546436
-
Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells
-
Crocker IC, Townley RG, Khan MM. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. J Invest Dermatol 1996;107:51-6
-
(1996)
J Invest Dermatol
, vol.107
, pp. 51-56
-
-
Crocker, I.C.1
Townley, R.G.2
Khan, M.M.3
-
92
-
-
84918542241
-
Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
-
Hanifin JM, Chan SC, Cheng JB, et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. Clin Exp Med 2012;12:241-5
-
(2012)
Clin Exp Med
, vol.12
, pp. 241-245
-
-
Hanifin, J.M.1
Chan, S.C.2
Cheng, J.B.3
-
93
-
-
84870416119
-
Recombinant human interferon gamma in treatment of atopic dermatitis
-
Panahi Y, Davoudi SM, Madanchi N, Abolhasani E. Recombinant human interferon gamma in treatment of atopic dermatitis. Clin Exp Med 2012;12:241-5
-
(2012)
Clin Exp Med
, vol.12
, pp. 241-245
-
-
Panahi, Y.1
Davoudi, S.M.2
Madanchi, N.3
Abolhasani, E.4
-
94
-
-
0036091342
-
Atopic dermatitis: The role of recombinant interferon-gamma therapy
-
Chang TT, Stevens SR. Atopic dermatitis: the role of recombinant interferon-gamma therapy. Am J Clin Dermatol 2002;3:175-83
-
(2002)
Am J Clin Dermatol
, vol.3
, pp. 175-183
-
-
Chang, T.T.1
Stevens, S.R.2
-
95
-
-
66149140228
-
IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis
-
Morioka T, Yamanaka K, Mori H, et al. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis. Br J Dermatol 2009;160:1172-9
-
(2009)
Br J Dermatol
, vol.160
, pp. 1172-1179
-
-
Morioka, T.1
Yamanaka, K.2
Mori, H.3
-
96
-
-
84879401471
-
Dupilumab in persistent asthma with elevated eosinophil levels
-
Wenzel S, Ford L Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. New Engl J Med 2013;368:2455-66
-
(2013)
New Engl J Med
, vol.368
, pp. 2455-2466
-
-
Wenzel, S.1
Ford, L.2
Pearlman, D.3
-
97
-
-
1142285210
-
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T-cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are diseasespecific markers for atopic dermatitis
-
Hijnen D, De Bruin-Weller M, Oosting B, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T-cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are diseasespecific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-40
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 334-340
-
-
Hijnen, D.1
De Bruin-Weller, M.2
Oosting, B.3
-
98
-
-
84899942974
-
Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis
-
Kimura T, Sugaya M, Suga H, et al. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis. Acta Derm Venereol 2014;94(3):331-2
-
(2014)
Acta Derm Venereol
, vol.94
, Issue.3
, pp. 331-332
-
-
Kimura, T.1
Sugaya, M.2
Suga, H.3
-
99
-
-
84903887689
-
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis
-
Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014;371:130-9
-
(2014)
N Engl J Med
, vol.371
, pp. 130-139
-
-
Beck, L.A.1
Thaçi, D.2
Hamilton, J.D.3
-
101
-
-
84862905945
-
A pro-fibrotic role for interleukin-4 in cardiac pressure overload
-
Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res 2012;95(1):77-85
-
(2012)
Cardiovasc Res
, vol.95
, Issue.1
, pp. 77-85
-
-
Kanellakis, P.1
Ditiatkovski, M.2
Kostolias, G.3
Bobik, A.4
|